Experts recommend that patients protect themselves from infection by taking certain precautions, many of which may make for some socially awkward moments, like declining a handshake at a business meeting. But there are ways to manage both your health and your social relationships, and it often starts with a healthy dose of information. With a… Read More »Protecting yourself during cancer treatment
The US Food and Drug Administration (FDA), the Australian Therapeutic Goods Administration (TGA), and Health Canada (HC) today simultaneously approved a new two-drug combination for the treatment of advanced endometrial carcinoma. The three agencies worked together under the umbrella of Project Orbis, a new FDA initiative that allows concurrent submission and review of oncology products among… Read More »US, Canada, Australia Simultaneously Approve Endometrial Cancer Combo
What are mental health problems? Our mental health is just like our physical health: everybody has it and we need to take care of it. Mental health problems affect around one in four people in any given year. They range from common problems, such as depression and anxiety, to rarer problems such as schizophrenia and bipolar disorder. Taking care of our… Read More »World Mental Health Day…
Mahatma Gandhi’s birthday (Gandhi Jayanti or Mahatma Gandhi Jayanti) is a gazetted holiday in India on October 2 each year. It marks the anniversary of Mahatma Gandhi’s birth on October 2, 1869. Gandhi is remembered for his contributions towards the Indian freedom struggle. Is Mahatma Gandhi Jayanti a Public Holiday? Mahatma Gandhi Jayanti is a public holiday.… Read More »Happy Gandhi Jayanti
Undiagnosed, untreated attention-deficit/hyperactivity disorder (ADHD) can wreak havoc on your life, and it can also impact your loved ones. Each year, we recognize ADHD Awareness Month in October as a time to celebrate the progress made in ADHD education and advocacy, understand the work that still needs to be done, and raise awareness about… Read More »National ADHD Awareness Month – October 2019
The US Food and Drug Administration (FDA) issued a warning today that the commonly prescribed breast cancer therapies known as cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors may cause rare but severe inflammation of the lungs. The related products include palbociclib (Ibrance, Pfizer), ribociclib (Kisqali, Novartis), and abemaciclib (Verzenio, Eli Lilly), which are approved for use in patients with hormone receptor (HR)-positive, human epidermal… Read More »Breast Cancer Drugs May Severely Inflame Lungs, FDA Warns
The US Food and Drug Administration (FDA) has approved istradefylline (Nourianz, Kyowa Kirin) tablets as add-on treatment to levodopa/carbidopa in adults with Parkinson’s disease (PD) experiencing “off” episodes. Istradefylline is a selective adenosine A2A receptor antagonist. Its effectiveness in treating “off” episodes in patients with PD taking levodopa/carbidopa was shown in four 12-week, placebo-controlled clinical studies that included a total of 1143 participants.… Read More »FDA OKs Istradefylline for Parkinson’s Disease ‘Off’ Episodes